Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
After finishing at $2.5 in the prior trading day, Codexis Inc (NASDAQ: CDXS) closed at $2.52, up 0.80%. In other words, the price has increased by $0.80 from its previous closing price. On the day, 0.5 million shares were traded. CDXS stock price reached its highest trading level at $2.52 during the session, while it also had its lowest trading level at $2.42.
Ratios:
Our goal is to gain a better understanding of CDXS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.70 and its Current Ratio is at 5.82. In the meantime, Its Debt-to-Equity ratio is 1.24 whereas as Long-Term Debt/Eq ratio is at 1.19.
On May 30, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.Cantor Fitzgerald initiated its Overweight rating on May 30, 2024, with a $11 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 31 ’25 when Opaleye Management Inc. bought 84,220 shares for $2.68 per share. The transaction valued at 225,710 led to the insider holds 12,544,220 shares of the business.
Opaleye Management Inc. bought 780 shares of CDXS for $2,211 on Aug 04 ’25. The 10% Owner now owns 12,545,000 shares after completing the transaction at $2.83 per share. On Jul 29 ’25, another insider, Opaleye Management Inc., who serves as the 10% Owner of the company, bought 8,422 shares for $2.82 each. As a result, the insider paid 23,750 and bolstered with 12,458,422 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDXS now has a Market Capitalization of 227474000 and an Enterprise Value of 230124016. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.98 while its Price-to-Book (P/B) ratio in mrq is 4.09. Its current Enterprise Value per Revenue stands at 4.026 whereas that against EBITDA is -4.402.
Stock Price History:
The Beta on a monthly basis for CDXS is 2.58, which has changed by -0.20253164 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, CDXS has reached a high of $6.08, while it has fallen to a 52-week low of $1.90. The 50-Day Moving Average of the stock is -5.70%, while the 200-Day Moving Average is calculated to be -18.60%.
Shares Statistics:
The stock has traded on average 947.74K shares per day over the past 3-months and 569980 shares per day over the last 10 days, according to various share statistics. A total of 90.25M shares are outstanding, with a floating share count of 87.50M. Insiders hold about 3.07% of the company’s shares, while institutions hold 79.44% stake in the company. Shares short for CDXS as of 1757894400 were 5632430 with a Short Ratio of 5.94, compared to 1755216000 on 5189591. Therefore, it implies a Short% of Shares Outstanding of 5632430 and a Short% of Float of 6.34.
Earnings Estimates
. The current rating of Codexis Inc (CDXS) reflects the combined expertise of 3.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.08 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.5 and -$0.68 for the fiscal current year, implying an average EPS of -$0.6. EPS for the following year is -$0.62, with 2.0 analysts recommending between -$0.61 and -$0.63.
Revenue Estimates
7 analysts predict $18.52M in revenue for. The current quarter. It ranges from a high estimate of $20.2M to a low estimate of $16.27M. As of. The current estimate, Codexis Inc’s year-ago sales were $12.83MFor the next quarter, 7 analysts are estimating revenue of $24.3M. There is a high estimate of $26.87M for the next quarter, whereas the lowest estimate is $22.21M.
A total of 7 analysts have provided revenue estimates for CDXS’s current fiscal year. The highest revenue estimate was $67.7M, while the lowest revenue estimate was $62.82M, resulting in an average revenue estimate of $65.66M. In the same quarter a year ago, actual revenue was $59.34MBased on 6 analysts’ estimates, the company’s revenue will be $79.88M in the next fiscal year. The high estimate is $87.6M and the low estimate is $75.5M.
